Salgado F J, Vela E, Martín M, Franco R, Nogueira M, Cordero O J
Department of Biochemistry and Molecular Biology, University of Santiago de Compostela, Galicia, Spain.
Cytokine. 2000 Jul;12(7):1136-41. doi: 10.1006/cyto.1999.0643.
Among the cellular pathways activated by IL-12, we had previously found that both the percentage and intensity of CD26(+)cells in the PHA-stimulated T cells increased when IL-12 was present (independently of its CD4 or CD8 phenotype). Now, we examined the molecular mechanisms of this IL-12-mediated effect. The IL-12 regulation pathway is dependent of de novo protein synthesis and independent of cytokine secretion. Our results show two transcripts for CD26 in PBMC for the first time and no regulation by ILs at this level. Furthermore, secretion of the serum forms of CD26/DPPIV were not affected by IL-12. Interestingly, assays with neutralizing mAbs against TNF-alpha suggest that this cytokine negatively modulates CD26 expression. The fact that translation and probably translocation of CD26 toward the cell surface can be regulated by IL-12 and TNF-alpha reveals new aspects about the control of this T(H1)marker.
在白细胞介素-12(IL-12)激活的细胞通路中,我们之前发现,当存在IL-12时(无论其CD4或CD8表型如何),PHA刺激的T细胞中CD26(+)细胞的百分比和强度都会增加。现在,我们研究了这种IL-12介导效应的分子机制。IL-12调节途径依赖于从头合成蛋白质,且不依赖于细胞因子分泌。我们的结果首次显示外周血单核细胞(PBMC)中CD26有两种转录本,且在此水平上不受白细胞介素的调节。此外,血清形式的CD26/二肽基肽酶IV(DPPIV)的分泌不受IL-12影响。有趣的是,用抗TNF-α的中和单克隆抗体进行的试验表明,这种细胞因子对CD26表达有负调节作用。CD26向细胞表面的翻译以及可能的转运可受IL-12和TNF-α调节,这一事实揭示了关于这种辅助性T细胞1型(TH1)标志物控制的新方面。